Citation: Gv. Mcdonnell et Sa. Hawkins, An assessment of the spectrum of disability and handicap in multiple sclerosis: a population-based study, MULT SCLER, 7(2), 2001, pp. 111-117
Authors:
Boylan, MT
Crockard, AD
McDonnell, GV
McMillan, SA
Hawkins, SA
Citation: Mt. Boylan et al., Serum and cerebrospinal fluid soluble Fas levels in clinical subgroups of multiple sclerosis, IMMUNOL LET, 78(3), 2001, pp. 183-187
Authors:
McDonnell, GV
McCann, JP
Craig, JJ
Crone, M
Citation: Gv. Mcdonnell et al., Prevalence of the Chiari/hydrosyringomyelia complex in adults with spina bifida: Preliminary results, EUR J PED S, 10, 2000, pp. 18-19
Citation: Gv. Mcdonnell et Sa. Hawkins, Multiple sclerosis in Northern Ireland: A historical and global perspective, ULSTER MED, 69(2), 2000, pp. 97-105
Authors:
McDonnell, GV
Kirk, CW
Hawkins, SA
Graham, CA
Citation: Gv. Mcdonnell et al., An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis, J NEUR SCI, 176(1), 2000, pp. 4-12
Citation: Gv. Mcdonnell et Sa. Hawkins, Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors - Reply, J NE NE PSY, 68(3), 2000, pp. 396-396
Authors:
McMillan, SA
McDonnell, GV
Douglas, JP
Hawkins, SA
Citation: Sa. Mcmillan et al., Evaluation of the clinical utility of cerebrospinal fluid (CSF) indices ofinflammatory markers in multiple sclerosis, ACT NEUR SC, 101(4), 2000, pp. 239-243
Authors:
Armstrong, MA
McDonnell, GV
Graham, CA
Kirk, CW
Droogan, AG
Hawkins, SA
Citation: Ma. Armstrong et al., Relationship between tumour necrosis factor-alpha (TNF alpha) production and a specific multiple sclerosis (MS) associated TNF gene haplotype, MULT SCLER, 5(3), 1999, pp. 165-170
Authors:
McDonnell, GV
Kirk, CW
Hawkins, SA
Graham, CA
Citation: Gv. Mcdonnell et al., Lack of association of transforming growth factor (TGF)-beta 1 and beta 2 gene polymorphisms with multiple sclerosis (MS) in Northern Ireland, MULT SCLER, 5(2), 1999, pp. 105-109
Authors:
McDonnell, GV
Kirk, CW
Middleton, D
Droogan, AG
Hawkins, SA
Patterson, CC
Graham, CA
Citation: Gv. Mcdonnell et al., Genetic association studies of tumour necrosis factor alpha and beta and tumour necrosis factor receptor 1 and 2 polymorphisms across the clinical spectrum of multiple sclerosis, J NEUROL, 246(11), 1999, pp. 1051-1058
Citation: Gv. Mcdonnell et Sa. Hawkins, Major histocompatibility complex class II alleles and the course and outcome of MS, NEUROLOGY, 53(4), 1999, pp. 893-893
Authors:
Boylan, MT
Crockard, AD
McDonnell, GV
Armstrong, MA
Hawkins, SA
Citation: Mt. Boylan et al., CD80 (B7-1) and CD86 (B7-2) expression in multiple sclerosis patients: clinical subtype specific variation in peripheral monocytes and B cells and lack of modulation by high dose methylprednisolone, J NEUR SCI, 167(2), 1999, pp. 79-89
Authors:
McDonnell, GV
Mawhinney, H
Graham, CA
Hawkins, SA
Middleton, D
Citation: Gv. Mcdonnell et al., A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis, J NEUR SCI, 165(1), 1999, pp. 77-83
Citation: Sa. Hawkins et Gv. Mcdonnell, Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors, J NE NE PSY, 67(2), 1999, pp. 148-152
Citation: Gv. Mcdonnell et Sa. Hawkins, High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition, J NE NE PSY, 66(3), 1999, pp. 411-411